Research & Labs

UCLA Researchers Identify Previously Unobserved Type of White Blood Cell Involved in Development of Pimples

Acne affects more than 45 million people and is ranked third among chronic skin conditions that cause disability....

UCLA researchers offer roadmap for identifying new neuroprotective treatments by leveraging sex differences

A new study from UCLA researchers provides a strategy for finding treatments optimally tailored for women and men to prevent cognitive decline in agin...

UCLA Researchers Provide New Framework for Studying Brain Organization

UCLA researchers and colleagues at Emory University and other research centers have combined data simulation and experimental observation to bridge a ...

UCLA researchers receive $6 million from NIH to explore new pancreatic cancer therapies

UCLA researchers receive grant from Prostate Cancer Foundation

The UCLA Ahmanson Translational Theranostics prostate cancer research group is part of a multi-institutional team that will receive a $10 million Pros...

UCLA Researchers Use Artificial Intelligence Tools to Speed Critical Information on Drug Overdose Deaths

An automated process based on computer algorithms that can read text from medical examiners' death certificates can substantially speed up data collec...

UCLA scientists awarded $10M by NIH to study developing brain

Two scientists at the David Geffen School of Medicine at UCLA have been awarded nearly $10 million from the National Institutes of Health's Brain Rese...

UCLA scientists develop off-the-shelf immunotherapy for metastatic kidney cancer

An off-the-shelf immunotherapy for metastatic kidney cancer uses specially engineered immune cells to attack cancer tumors.

UCLA scientists develop off-the-shelf immunotherapy for ovarian cancer

UCLA researchers have developed a novel off-the-shelf immunotherapy for ovarian cancer that has been shown to be more effective at f

UCLA scientists receive $16.1 million in CIRM grants to advance novel stem-cell based treatments

UCLA scientists receive $4.7 million in CIRM grants to advance novel stem cell-based treatments for female-specific diseases and leukemia in Down syndrome

UCLA scientists have received $4.7 million in grants from the California Institute for Regenerative Medicine to advance stem cell treatments.

UCLA scientists receive $6.9M in CIRM grants to develop novel stem-cell based therapies

Researchers received more than $6.9 million in grants from the California Institute for Regenerative Medicine.

UCLA scientists receive grants from California’s stem cell agency to develop therapies for white matter stroke and XLA

UCLA scientists reprogram stem cells to create renewable cancer-fighting T cells

UCLA scientists discuss a clinical trial that used engineered T cells and stem cells to create a renewable supply of cancer-fighting immune cells.

UCLA scientists use mini-organ models to uncover hantavirus secrets, point to treatments

A UCLA-built organoid model paves the way for uncovering treatments for hantaviruses, deadly rodent-borne viruses with no current treatments.